ciprofloxacin has been researched along with Epidermolysis Bullosa Dystrophica in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin-resistant SA was found significantly predominant in chronic wounds (**P < ." | 1.91 | Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. ( Acevedo, F; Arancibia, E; Fuentes, I; Morandé, P; Oróstica, K; Palisson, F; Porte, L; Rebolledo-Jaramillo, B; Varela, C; Yubero, MJ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuentes, I | 1 |
| Yubero, MJ | 1 |
| Morandé, P | 1 |
| Varela, C | 1 |
| Oróstica, K | 1 |
| Acevedo, F | 1 |
| Rebolledo-Jaramillo, B | 1 |
| Arancibia, E | 1 |
| Porte, L | 1 |
| Palisson, F | 1 |
1 other study available for ciprofloxacin and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
Topics: Ciprofloxacin; Corynebacterium diphtheriae; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica | 2023 |